Biotech entity
All 1 tracked stories fall under one category: pharma. Chris Seeger is most often covered alongside Erik Haas, which appears in 1 of these 1 story. We currently track 1 Biotech story that mention Chris Seeger, all published on July 28, 2026.
Last mentioned: Jul 28, 2026
Entity pulse
Coverage balance Negative coverage leads. Negative coverage exceeds positive coverage by 100 percentage points.
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
All 1 tracked stories fall under one category: pharma. Chris Seeger is most often covered alongside Erik Haas, which appears in 1 of these 1 story. We currently track 1 Biotech story that mention Chris Seeger, all published on July 28, 2026. Each carries 3 original sources on average.
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 5 Biotech stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering Chris Seeger. Shared-story counts are live from our verified record — not editorial picks.
The settlement removes a major litigation distraction, allowing Johnson & Johnson to redirect resources toward its core pharmaceutical and medtech segments, which generate $85B in annual revenue.
Source: 1190talkradio.iheart.com · manilatimes.net
Chris Seeger is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
